While changes in CgA can indicate treatment response if declining, or conversely progression of disease if rising, there are debates regarding the role of CgA as a prognostic biomarker because of its high false-positivity (related to proton pump inhibitor, kidney failure, and heart disease) and false-negativity (non-secretory tumors) 32. Here, CGA is linked to heart disorder.